Efficacy, safety and predictors of combined fruquintinib with programmed death-1 inhibitors for advanced microsatellite-stable colorectal cancer: A retrospective study

BACKGROUND: Research findings have revealed that combining anti-angiogenesis inhibitors with programmed death-1(PD-1) inhibitors can reverse the immunosuppressive tumor microenvironment and enhance the antitumor immune response. To explore the therapeutic options for breaking immune tolerance in mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weijie, Zhang, Zhongyue, Lou, Shitong, Li, Donghui, Ma, Zhijun, Xue, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472213/
https://www.ncbi.nlm.nih.gov/pubmed/36119532
http://dx.doi.org/10.3389/fonc.2022.929342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472213/
https://www.ncbi.nlm.nih.gov/pubmed/36119532
http://dx.doi.org/10.3389/fonc.2022.929342

Ejemplares similares